Aldo Rafael-Yarihuaman, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dallas, TXNPI 1043462609
Payments from drug & device makers
Across 470 payments — averaging $302.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$115K
- Edwards Lifesciences$16K
- Medtronic$7K
- Atricure, Inc.$1K
- Getinge USA Sales, LLC$960
- Abiomed$649
- plus $2K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 210 | $114,590 |
| Edwards Lifesciences | 71 | $16,093 |
| Medtronic(2 entities) | 89 | $7,348 |
| Atricure, Inc. | 10 | $1,055 |
| Getinge USA Sales, LLC | 20 | $960 |
| Abiomed | 11 | $649 |
| Baxter Healthcare | 12 | $519 |
| Kls-martin L.p. | 13 | $246 |
| Pylant Medical | 2 | $130 |
| Boston Scientific | 1 | $102 |
| Johnson & Johnson | 4 | $92 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $73 |
| LSI Solutions Inc | 1 | $73 |
| Chiesi USA, Inc. | 4 | $70 |
| Davol Inc. | 2 | $51 |
| E.r. Squibb & Sons, L.L.C. | 2 | $51 |
| Potrero Medical, Inc. | 1 | $44 |
| Kestra Medical Technology Services, Inc. | 3 | $44 |
| Smith+Nephew | 1 | $24 |
| AstraZeneca | 1 | $21 |
| Novartis | 1 | $20 |
| BD | 1 | $19 |
| Mimedx Group, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Molnlycke Health Care US, LLC | 1 | $13 |
| Biocomposites Inc | 1 | $10 |
How this compares
$142,339 in reported general payments places this provider in the 90th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Dallas
- Robert HebelerDallas$1.2M
- Dan MeyerDallas$518K
- Todd DeweyDallas$389K
- Gary SchwartzDallas$317K
- Matthais PeltzDallas$279K
- Michael WaitDallas$245K
- Michael JessenDallas$177K
- Juan MachannafordDallas$164K
- Robert SmithPlano$2.9M
- Michael ReardonHouston$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.